STOCK TITAN

Health Catalyst, Inc - HCAT STOCK NEWS

Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.

Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.

The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.

Health Catalyst has recently gained recognition with several achievements:

  • VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
  • MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
  • Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
  • Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.

Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.

Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.

For more information, visit the Health Catalyst Investor Relations page.

Rhea-AI Summary

Health Catalyst (HCAT) has announced a strategic partnership with Northwell Health, aimed at improving patient care through enhanced data and analytics capabilities. This collaboration will utilize Health Catalyst's cloud-based solutions to optimize data management and integration with Electronic Medical Records (EMR). Northwell, the largest healthcare provider in New York, aims to leverage insights from Health Catalyst's offerings to better serve over 11 million patients. The initiative also includes access to COVID-19 specific tools, further supporting Northwell's mission to transform healthcare delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.5%
Tags
none
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire Vitalware, a provider of revenue workflow optimization technology based in Yakima, Washington. Vitalware's solutions include a Best in KLAS chargemaster management tool and products for Revenue Integrity and Price Transparency. This acquisition aims to enhance Health Catalyst’s analytics capabilities on its DOS™ platform, integrating charge and revenue data with claims and cost data. The transaction will be funded through a mix of cash and stock and is expected to close in Q3 or Q4 of 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.5%
Tags
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) announced participation in two upcoming virtual investor conferences. Dan Burton (CEO), Patrick Nelli (CFO), and Adam Brown (SVP, Investor Relations) will be featured. The first event is the Verity Research HCIT / Services Conference on August 12, 2020, at 4:00 p.m. EST, followed by the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020, at 10:00 a.m. EST. Health Catalyst focuses on healthcare improvement through data and analytics, leveraging over 100 million patient records to support informed decision-making.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
conferences
Rhea-AI Summary

On July 28, 2020, Health Catalyst (Nasdaq: HCAT) announced its new Financial Impact Recovery applications aimed at helping healthcare systems recover financially from the effects of COVID-19. These tools enable hospitals to prioritize and monitor backlogs in elective surgeries and outpatient visits, while also streamlining revenue cycles. With rapid implementation timelines, the applications have already been adopted by 15 clients, including Banner Health, which emphasized their need for timely data analytics to enhance financial performance amid the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.39%
Tags
covid-19
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) has announced a definitive agreement to acquire healthfinch, a company that enhances EMR workflows through automation and analytics. This acquisition aims to strengthen Health Catalyst's Population Health portfolio, previously bolstered by the Able Health acquisition. The healthfinch technology will be integrated into Health Catalyst’s Data Operating System, providing actionable insights and improving patient care efficiency. The transaction is expected to close in Q3 2020 and will be funded through a mix of stock and cash.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.69%
Tags
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) announced its participation in the COVID-19 Evidence Accelerator, a public-private partnership aimed at enhancing the understanding of COVID-19 using real-world data. The company will contribute insights from its COVID-19 National Registry, which includes data from over 64,000 patients and 500,000 with COVID-related symptoms. These efforts are intended to improve treatment outcomes and inform regulatory decisions. Health Catalyst aims to leverage its data and analytics expertise to help healthcare organizations better diagnose and manage COVID-19.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.45%
Tags
partnership covid-19
Rhea-AI Summary

Health Catalyst, a leader in data and analytics for healthcare, announced their participation in two upcoming investor conferences. CEO Dan Burton will present at the William Blair 40th Annual Growth Stock Conference on June 10, 2020, at 1:20 p.m. CST, while CFO Patrick Nelli will speak at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, at 11:20 a.m. EST. The company supports healthcare organizations in making data-informed decisions, leveraging insights from over 100 million patient records.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
conferences
-
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) reported its Q1 2020 financial results, revealing a 28% increase in total revenue, reaching $45.1 million compared to $35.2 million in Q1 2019. Technology revenue grew by 23% to $24.7 million, and professional services revenue surged 36% to $20.4 million. Despite the revenue growth, the company faced a net loss of $17.5 million, a 27% increase from the previous year. Adjusted EBITDA improved by 11% year-over-year, indicating resilience amid the COVID-19 pandemic. Health Catalyst remains committed to supporting healthcare organizations during these challenging times.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
none
-
Rhea-AI Summary

Health Catalyst (HCAT) announced the appointment of Mark Templeton to its Board and the nominating and corporate governance committee, effective June 15, 2020. Templeton, former CEO of DigitalOcean, replaces Promod Haque after his term concludes at the annual stockholders meeting on June 12, 2020. Templeton brings over 20 years of experience, including 14 years as Citrix's CEO, where he significantly expanded the company. Dan Burton, CEO of Health Catalyst, expressed confidence in Templeton's capabilities to drive growth and support the company's mission to improve healthcare through data-informed decisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.8%
Tags
none

FAQ

What is the current stock price of Health Catalyst (HCAT)?

The current stock price of Health Catalyst (HCAT) is $5.68 as of January 21, 2025.

What is the market cap of Health Catalyst (HCAT)?

The market cap of Health Catalyst (HCAT) is approximately 338.6M.

What does Health Catalyst, Inc. do?

Health Catalyst provides data and analytics technology and services aimed at enhancing healthcare delivery through comprehensive data warehousing and process improvement solutions.

What are the main segments of Health Catalyst's business?

The main segments are Technology, which includes data platforms and analytics applications, and Professional Services, which offers analytics, implementation, strategic advisory, and improvement services.

What recent achievements has Health Catalyst made?

Health Catalyst's recent achievements include the top ranking of VitalCDM in the 2024 Best in KLAS, ONC-Health IT certification for MeasureAble™, QPP Qualified Registry approval for Able Health Registry, and the acquisition of Carevive Systems.

What is the adaptive data architecture?

The adaptive data architecture is a late-binding bus model that provides agility and flexibility, allowing quick implementation of data solutions tailored specifically for healthcare data complexities.

How does Health Catalyst generate its revenue?

Revenue is primarily generated through cloud-based subscription arrangements, time-based licensing, and maintenance and support fees.

What is the Best in KLAS ranking?

Best in KLAS is an annual report that recognizes top-performing software and services companies in healthcare, based on client feedback and evaluations.

What is the significance of the MeasureAble™ ONC-Health IT certification?

The certification allows MeasureAble™ to be used for various quality reporting programs, ensuring compliance with U.S. Department of Health and Human Services standards.

How does the acquisition of Carevive Systems benefit Health Catalyst?

The acquisition enhances Health Catalyst's oncology data analytics capabilities, improving patient care and providing insights into patient-reported outcomes and oncology registry data.

How does Health Catalyst support its clients?

Health Catalyst supports its clients through a combination of advanced data platforms, analytics software, and professional services to drive measurable improvements in clinical, financial, and operational metrics.

Where can I find more information about Health Catalyst's financial performance?

You can find detailed financial information and updates on Health Catalyst's Investor Relations page at https://ir.healthcatalyst.com/.
Health Catalyst, Inc

Nasdaq:HCAT

HCAT Rankings

HCAT Stock Data

338.62M
59.26M
2.68%
90.79%
4.2%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States of America
SOUTH JORDAN